Enhancing photoreceptor integration using microglia-derived secreted factors
使用小胶质细胞衍生的分泌因子增强光感受器整合
基本信息
- 批准号:9903319
- 负责人:
- 金额:$ 40.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-04-01 至 2021-03-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcuteAffectApoptosisAstrocytesBlindnessCell DeathCell TransplantationCellsClinicClinical TrialsCytoprotectionDataDegenerative DisorderDevelopmentDirect CostsDiseaseDisease ProgressionDopamineDopaminergic CellDrosophila genusEnvironmentFinancial HardshipGoalsHemocytesHomologous GeneImmuneImmunologic TestsInheritedInjectionsLightMammalsMicrogliaModelingMorphologyMusNatural regenerationNervous system structureNeuronsParkinson DiseasePatientsPhenotypePhotoreceptorsPlatelet-Derived Growth FactorPluripotent Stem CellsProcessProtocols documentationRecoveryRegenerative MedicineRegulationReplacement TherapyRetinaRetinal DegenerationRetinal DiseasesRetinal PhotoreceptorsRoleSocietiesSourceTestingTherapeuticTimeTissuesTransplantationUV inducedUltraviolet RaysVascular Endothelial Growth FactorsVisionWorkautocrinebaseexperimental studyflyfunctional restorationgenetic approachhuman diseasehuman embryonic stem cellhuman embryonic stem cell transplantationimmune activationimprovedinduced pluripotent stem cellinsightmacrophagemonocytemouse modelneuroprotectionneurotrophic factornovel therapeutic interventionparacrinephotoreceptor degenerationpreventpublic health relevancerecruitregenerativerepairedresponseretinal damagestem cellssuccesstissue regenerationtissue repairultraviolet damage
项目摘要
DESCRIPTION (provided by applicant): The retina, like many other regions of the nervous system, is subject to a variety of inherited and acquired degenerative conditions. These conditions often result in the degeneration of the photoreceptors, the main light sensing cells in the retina. Despite the loss of photoreceptors, the inner retinal circuitry is intact for many year, and this has led to the possibility of photoreceptor replacement as a potential therapy. Cell replacement strategy is important as the loss of photoreceptors in the mammalian retina is not associated with any effective regeneration from resident cells. A potential source of cellular replacement could be pluripotent stem cells. There are a number of groups looking into the potential of stem cell derived RPE including an approved clinical trial for RPE cell replacement for AMD and Stargardt dystrophy. However, as the disease progresses to vision loss, patients will require replacement of the lost photoreceptor cells as well. Although a number of groups have shown integration of photoreceptors in the mouse retina, the overall efficiency is really low.
Additionally, the role of the microglia in this process has largely been unexplored. This proposal aims to look at the role of microglia-derived neurotrophic factors in both retinal repair and regenerative medicine. We will use a cross-species approach to identify and carry out basic studies in flies and apply the result in mammalian retinas.
描述(由申请人提供):与神经系统的许多其他区域一样,视网膜会遭受各种遗传性和后天性退化状况的影响,这些状况通常会导致感光细胞(视网膜中主要的感光细胞)退化。尽管光感受器丧失,但视网膜内部电路多年来仍保持完整,这使得光感受器替代成为一种潜在疗法的可能性,因为细胞替代策略非常重要,因为光感受器的丧失。哺乳动物视网膜与驻留细胞的任何有效再生无关,细胞替代的潜在来源可能是多能干细胞,有许多小组正在研究干细胞衍生的 RPE 的潜力,其中包括一项已批准的 RPE 细胞替代临床试验。然而,随着疾病进展到视力丧失,患者也需要更换丢失的感光细胞,尽管许多研究小组已经证明小鼠视网膜中存在感光细胞整合,但总体效率较高。确实很低。
此外,小胶质细胞在此过程中的作用很大程度上尚未被探索,该提案旨在研究小胶质细胞衍生的神经营养因子在视网膜修复和再生医学中的作用。对果蝇的基础研究并将结果应用于哺乳动物视网膜。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Small Molecule-Based Retinal Differentiation of Human Embryonic Stem Cells and Induced Pluripotent Stem Cells.
基于小分子的人胚胎干细胞和诱导多能干细胞的视网膜分化。
- DOI:
- 发表时间:2018-06-20
- 期刊:
- 影响因子:0.8
- 作者:Zhu, Jie;Lamba, Deepak A
- 通讯作者:Lamba, Deepak A
Generation of Transplantable Retinal Photoreceptors from a Current Good Manufacturing Practice-Manufactured Human Induced Pluripotent Stem Cell Line.
从当前良好生产规范制造的人类诱导多能干细胞系中产生可移植的视网膜感光器。
- DOI:
- 发表时间:2018-02
- 期刊:
- 影响因子:6
- 作者:Zhu, Jie;Reynolds, Joseph;Garcia, Thelma;Cifuentes, Helen;Chew, Shereen;Zeng, Xianmin;Lamba, Deepak Ashok
- 通讯作者:Lamba, Deepak Ashok
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Deepak Ashok Lamba其他文献
Deepak Ashok Lamba的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Deepak Ashok Lamba', 18)}}的其他基金
Mechanistic analysis and allellic genome editing of iPSC-derived dominant LCA model
iPSC 衍生的显性 LCA 模型的机制分析和等位基因组编辑
- 批准号:
10319983 - 财政年份:2021
- 资助金额:
$ 40.31万 - 项目类别:
Mechanistic analysis and allellic genome editing of iPSC-derived dominant LCA model
iPSC 衍生的显性 LCA 模型的机制分析和等位基因组编辑
- 批准号:
10370911 - 财政年份:2021
- 资助金额:
$ 40.31万 - 项目类别:
Mechanistic analysis and allellic genome editing of iPSC-derived dominant LCA model
iPSC 衍生的显性 LCA 模型的机制分析和等位基因组编辑
- 批准号:
10514970 - 财政年份:2021
- 资助金额:
$ 40.31万 - 项目类别:
Lamba_Admin_Supp_Re_Entry_Mar2022
Lamba_Admin_Supp_Re_Entry_Mar2022
- 批准号:
10596052 - 财政年份:2021
- 资助金额:
$ 40.31万 - 项目类别:
Mechanistic analysis and allellic genome editing of iPSC-derived dominant LCA model
iPSC 衍生的显性 LCA 模型的机制分析和等位基因组编辑
- 批准号:
10531241 - 财政年份:2021
- 资助金额:
$ 40.31万 - 项目类别:
Mechanistic analysis and allellic genome editing of iPSC-derived dominant LCA model
iPSC 衍生的显性 LCA 模型的机制分析和等位基因组编辑
- 批准号:
10723137 - 财政年份:2021
- 资助金额:
$ 40.31万 - 项目类别:
Mechanistic analysis and allellic genome editing of iPSC-derived dominant LCA model
iPSC 衍生的显性 LCA 模型的机制分析和等位基因组编辑
- 批准号:
10514970 - 财政年份:2021
- 资助金额:
$ 40.31万 - 项目类别:
Enhancing photoreceptor integration using microglia-derived secreted factors
使用小胶质细胞衍生的分泌因子增强光感受器整合
- 批准号:
9250155 - 财政年份:2016
- 资助金额:
$ 40.31万 - 项目类别:
相似国自然基金
AMPKα1线粒体定位对急性肾损伤影响及其机制
- 批准号:82360142
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
超急性期免疫表征影响脑卒中预后研究
- 批准号:
- 批准年份:2023
- 资助金额:10 万元
- 项目类别:
高甘油三酯通过TLR4/caspase-8影响急性胰腺炎CD4+T细胞程序性死亡的机制研究
- 批准号:82360135
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
蜗牛粘液糖胺聚糖影响中性粒细胞粘附和迁移在治疗急性呼吸窘迫综合征中的作用研究
- 批准号:82360025
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Climate Change Effects on Pregnancy via a Traditional Food
气候变化通过传统食物对怀孕的影响
- 批准号:
10822202 - 财政年份:2024
- 资助金额:
$ 40.31万 - 项目类别:
An immunotherapeutic IgY formulation against norovirus diarrhea
一种针对诺如病毒腹泻的免疫治疗 IgY 制剂
- 批准号:
10693530 - 财政年份:2023
- 资助金额:
$ 40.31万 - 项目类别:
Sensitivity to Cannabis Effects and Cue Reactivity as Markers of a Developing Disorder in Adolescents
对大麻效应的敏感性和提示反应性作为青少年发育障碍的标志
- 批准号:
10586397 - 财政年份:2023
- 资助金额:
$ 40.31万 - 项目类别:
A mobile health framework for left ventricular end diastolic pressure diagnostics and monitoring.
用于左心室舒张末压诊断和监测的移动健康框架。
- 批准号:
10601929 - 财政年份:2023
- 资助金额:
$ 40.31万 - 项目类别:
Immune recognition of Klebsiella pneumoniae O2v1 and O2v2 O-antigen subtypes
肺炎克雷伯菌 O2v1 和 O2v2 O 抗原亚型的免疫识别
- 批准号:
10739041 - 财政年份:2023
- 资助金额:
$ 40.31万 - 项目类别: